Crossmark

Improved Variant Detection in Clinical Myeloid NGS Testing by Supplementing a Commercial Myeloid NGS Assay with Custom or Extended Data Filtering and Accessory Fragment Analysis

Crossref DOI link: https://doi.org/10.1007/s40291-021-00519-5

Published Online: 2021-03-09

Published Print: 2021-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schejbel, Lone https://orcid.org/0000-0003-3677-3227
Novotny, Guy Wayne

Breinholt, Marie Fredslund

El Fassi, Daniel

Schöllkopf, Claudia

Hogdall, Estrid

Nørgaard, Peter
License Information

Text and Data Mining valid from 2021-03-01

Version of Record valid from 2021-03-01
More Information

Article History

Accepted: 15 February 2021

First Online: 9 March 2021

Declarations

:

: Not applicable.

: L. Schejbel, G.W. Novotny, M.F. Breinholt, D.E. Fassi, C. Schöllkopf, E. Hogdall, and P. Nørgaard declare that they have no conflict of interest.

: The inclusion of patient data was approved by the Danish Patients Safety Authority (Case ID 31-1521-102).

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below